Commentary|Videos|July 11, 2025

Advocating for Patients With Psoriasis: Securing Access to Nonsteroidal Topicals Like Roflumilast

Fact checked by: Victoria Johnson

In this video, the last in a 6-part series, panelists discuss recent advancements in PsO management.

In this HCPLive RX Review Special Report, Mona Shahriari, MD, Associate Clinical Professor of Dermatology at Yale University, sits down with David Hartigan, a biologic coordinator with Biologic Coordinators of Dermatology, to discuss strategies for overcoming access challenges to non-steroidal topicals like roflumilast foam for people with plaque psoriasis (PsO) on the scalp.